Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Verani

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
MMWR. Morbidity and Mortality Weekly Report|May 5, 2022
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022Namrata Prasad, Gordana Derado, Srinivas Acharya Nanduri, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2009
Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infectionJennifer R Verani, Amy Seitz, Robert H Gilman, et al.
The Lancet. Global Health|June 18, 2021
Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studiesNaor Bar-Zeev, Todd D Swarthout, Dean B Everett, et al.
MMWR. Morbidity and Mortality Weekly Report|March 18, 2021
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021Amadea Britton, Kara M Jacobs Slifka, Chris Edens, et al.
MMWR. Morbidity and Mortality Weekly Report|August 26, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021Srinivas Nanduri, Tamara Pilishvili, Gordana Derado, et al.
Plos One|October 11, 2019
Pathogen surveillance in the informal settlement, Kibera, Kenya, using a metagenomics approachRene S Hendriksen, Oksana Lukjancenko, Patrick Munk, et al.
Plos One|August 1, 2024
Acute febrile illness in Kenya: Clinical characteristics and pathogens detected among patients hospitalized with fever, 2017-2019Jennifer R Verani, Eric Ng' Eno, Elizabeth A Hunsperger, et al.
BMC Medicine|September 13, 2022
Prevalence of microcephaly and Zika virus infection in a pregnancy cohort in Kenya, 2017-2019Eric Osoro, Irene Inwani, Cyrus Mugo, et al.
The Journal of Infectious Diseases|April 11, 2022
Comparable Pregnancy Outcomes for HIV-Uninfected and HIV-Infected Women on Antiretroviral Treatment in KenyaCyrus Mugo, Ruth Nduati, Eric Osoro, et al.
Global Pediatric Health|December 11, 2023
Prevalence and Missed Cases of Respiratory Distress Syndrome Disease Amongst Neonatal Deaths Enrolled in the Kenya Child Health and Mortality Prevention Surveillance Network (CHAMPS) Program Between 2017 and 2021Harun O Owuor, Victor Akelo, Florence Murila, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
MMWR. Morbidity and Mortality Weekly Report|May 5, 2022
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022Namrata Prasad, Gordana Derado, Srinivas Acharya Nanduri, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2009
Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infectionJennifer R Verani, Amy Seitz, Robert H Gilman, et al.
The Lancet. Global Health|June 18, 2021
Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studiesNaor Bar-Zeev, Todd D Swarthout, Dean B Everett, et al.
MMWR. Morbidity and Mortality Weekly Report|March 18, 2021
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021Amadea Britton, Kara M Jacobs Slifka, Chris Edens, et al.
MMWR. Morbidity and Mortality Weekly Report|August 26, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021Srinivas Nanduri, Tamara Pilishvili, Gordana Derado, et al.
Plos One|October 11, 2019
Pathogen surveillance in the informal settlement, Kibera, Kenya, using a metagenomics approachRene S Hendriksen, Oksana Lukjancenko, Patrick Munk, et al.
Plos One|August 1, 2024
Acute febrile illness in Kenya: Clinical characteristics and pathogens detected among patients hospitalized with fever, 2017-2019Jennifer R Verani, Eric Ng' Eno, Elizabeth A Hunsperger, et al.
BMC Medicine|September 13, 2022
Prevalence of microcephaly and Zika virus infection in a pregnancy cohort in Kenya, 2017-2019Eric Osoro, Irene Inwani, Cyrus Mugo, et al.
The Journal of Infectious Diseases|April 11, 2022
Comparable Pregnancy Outcomes for HIV-Uninfected and HIV-Infected Women on Antiretroviral Treatment in KenyaCyrus Mugo, Ruth Nduati, Eric Osoro, et al.
Global Pediatric Health|December 11, 2023
Prevalence and Missed Cases of Respiratory Distress Syndrome Disease Amongst Neonatal Deaths Enrolled in the Kenya Child Health and Mortality Prevention Surveillance Network (CHAMPS) Program Between 2017 and 2021Harun O Owuor, Victor Akelo, Florence Murila, et al.
Pageof 17